Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH.
Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH.
复制标题
DOI:
10.1038/s41374-021-00626-1
复制
发表时间:
2021-12
影响因子:
5
通讯作者:
Szabo, Gyongyi
中科院分区:
文献类型:
--
作者:
Bala, Shashi;Ganz, Michal;Babuta, Mrigya;Zhuang, Yuan;Csak, Timea;Calenda, Charles D.;Szabo, Gyongyi
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease globally. miRNAs (miRs) regulate various cellular events that lead to NAFLD. In this study we tested the hypothesis that miR-155 is an important regulator of steatohepatitis and fibrosis pathways. Wild type (WT) or miR-155 deficient (KO) mice received a high fat-high cholesterol-high sugar-diet (HF-HC-HS) for 34 weeks and liver tissues were analyzed. In patients with non-alcoholic steatohepatitis and in the mouse model of HF-HC-HS diet we found increased miR-155 levels in the liver compared to normal livers. Upon HF-HC-HS diet feeding, miR-155 KO mice displayed less liver injury, decreased steatosis, and attenuation in fibrosis compared to WT mice. ALT, triglyceride levels and genes involved in fatty acid metabolic pathway were increased in WT mice whereas miR-155 KO mice showed attenuation in these parameters. HF-HC-HS diet induced significant increase in the expression of NLRP3 inflammasome components in the livers of WT mice compared to chow fed diet. Compared to WT mice, miR-155 KO showed attenuated induction in the NLRP3, ASC and caspase1 inflammasome expression on HF-HC-HS diet. Fibrosis markers such as collagen content and deposition, αSMA, Zeb2, and vimentin were all increased in WT mice and miR-155 KO mice showed attenuated fibrosis marker expression. Overall, our findings highlight a role for miR-155 in HF-HC-HS diet-induced steatosis and liver fibrosis. Non-alcoholic fatty liver disease is the most common cause of chronic liver disease globally and a risk factor for hepatocellular carcinoma. The study highlights the role of miR-155 in non-alcoholic steatohepatitis. miR-155-deficient mice displayed overall protection from diet-induced steatohepatitis and fibrosis. Therapeutic inhibition of miR-155 might be effective approach for treatment of non-alcoholic steatohepatitis.
登录
查看更多内容
影响因子:
25.7
作者:
Bala S;Csak T;Saha B;Zatsiorsky J;Kodys K;Catalano D;Satishchandran A;Szabo G
通讯作者:
Szabo G
影响因子:
4.9
作者:
Christmann RB;Wooten A;Sampaio-Barros P;Borges CL;Carvalho CR;Kairalla RA;Feghali-Bostwick C;Ziemek J;Mei Y;Goummih S;Tan J;Alvarez D;Kass DJ;Rojas M;de Mattos TL;Parra E;Stifano G;Capelozzi VL;Simms RW;Lafyatis R
通讯作者:
Lafyatis R
影响因子:
7.3
作者:
Alivernini S;Gremese E;McSharry C;Tolusso B;Ferraccioli G;McInnes IB;Kurowska-Stolarska M
通讯作者:
Kurowska-Stolarska M
DOI:
10.1016/j.jaci.2016.09.021
发表时间:
2017-06
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Kurowska-Stolarska M;Hasoo MK;Welsh DJ;Stewart L;McIntyre D;Morton BE;Johnstone S;Miller AM;Asquith DL;Millar NL;Millar AB;Feghali-Bostwick CA;Hirani N;Crick PJ;Wang Y;Griffiths WJ;McInnes IB;McSharry C
通讯作者:
McSharry C
影响因子:
5.4
作者:
Luo, Quan;Zeng, Jingxin;Zhang, Xibao
通讯作者:
Zhang, Xibao